In cancers, increased protein synthesis as part of an enhanced anabolic programme to sustain tumour growth is tied to an increase in the biogenesis of ribosomal proteins, ribosomal RNA, and translation factors to enhance translation capacity (Iritani & Eisenman, 1999; Inoki et al, 2002; Ma et al, 2005; Truitt & Ruggero, 2016) and is typically under the control of hyperactive oncogenes such as MYC. This evidence concerns the gene MYC and cancer.